Insmed Shares To Outperform Through 2018 After 'Slow Start,' Credit Suisse Says In Upgrade
April 23, 2018 at 12:20 PM EDT
Insmed Incorporated (NASDAQ: INSM) announced in late March that it has submitted a new drug application to the FDA for a ...
